Nanopharmaceutics IncOTC Pink - Current Information:TGRP
- LAST PRICE0.6000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.3620/ 25
- Ask / Lots1.0000/ 2
- Open / Previous Close0.0000 / 0.6000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Nanopharmaceutics Inc | 104.4M | -178.6x | --- |
BioXcel Therapeutics Inc | 99.3M | -0.4x | --- |
Barinthus Biotherapeutics PLC | 99.2M | -1.4x | --- |
Eliem Therapeutics Inc | 105.2M | -2.8x | --- |
Oramed Pharmaceuticals Inc | 95.2M | 18.7x | --- |
Bioatla Inc | 107.7M | -0.9x | --- |
Company Information
Nanopharmaceutics, Inc. is a clinical-stage specialty pharmaceutical company. The Company is developing oral, topical, and injectable products for cancer, central nervous system (CNS) disorders, and infectious diseases. The Company is developing a clinical pipeline of oral, topical and injectable small molecule drug candidates to treat human cancer, central nervous system (CNS) disorders and infectious diseases. The pipeline includes 10 clinical-stage proprietary and partnered programs including Triapine, Ammonium Tetrathiomolybdate and Aza-TdC, targeting cancer; NanoBUP, PRX-3140, NP-18-2, and NP-18-3, targeting CNS; and Ramoplanin and NanoDOX, targeting infectious disease. Leveraging its expertise in nanoparticle and fine-particle formulations, the Company is focused on formulation development aimed at improving drug absorption and stability. Triapine is a synthetic heterocyclic carboxaldehyde thiosemicarbazone with potential antineoplastic activity.
Contact Information
- Headquarters
- K-2-8 2nd. Floor Kuchai Business Park Jalan 1/127 Off Jalan Kuchai LamaKUALA LUMPUR, Malaysia 58200
- Phone
- ---
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $104.4M |
|---|---|
Revenue (TTM) | $1.0M |
Shares Outstanding | 174.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $0.00 |
Book Value | $-0.05 |
P/E Ratio | -178.6x |
Price/Sales (TTM) | 103.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -111.60% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
